Home > Research > Publications & Outputs > Small animal disease surveillance

Electronic data

Links

Text available via DOI:

View graph of relations

Small animal disease surveillance: Gastrointestinal disease, antibacterial prescription and Tritrichomonas foetus

Research output: Contribution to journalJournal article

Published
  • D.A. Singleton
  • E. Arsevska
  • S. Smyth
  • E.N. Barker
  • C. Jewell
  • B. Brant
  • F. Sánchez-Vizcaíno
  • S. Dawson
  • G.L. Pinchbeck
  • P.J.M. Noble
  • P.H. Jones
  • A.D. Radford
Close
<mark>Journal publication date</mark>14/02/2019
<mark>Journal</mark>Veterinary Record
Issue number7
Volume184
Number of pages6
Pages (from-to)211-216
Publication statusPublished
Original languageEnglish

Abstract

Report summary:

• Presentation for investigation and/or treatment of gastrointestinal (GI) disease comprised 3.0 per cent, 2.0 per cent and 1.9 per cent of total dog, cat and rabbit consultations respectively between 1 April 2017 and 31 October 2018
• Diarrhoea and vomiting without blood were the most frequently reported GI disease clinical signs (43.0 and 36.6 per cent in dogs, and 35.9 and 37.7 per cent in cats respectively)
• The proportion of GI disease consultations which prescribed antibiotics authorised for systemic administration (including oral and injectable formulations) decreased between April 2014 and October 2018
• The proportion of GI disease consultations which dispensed nutraceutical products advertised as being effective at managing primary GI disease (including prebiotics, probiotics etc.) increased between April 2014 and October 2018
• Between January 2011 and August 2018, 13.5 per cent of 20,194 feline faecal samples submitted to UK-based diagnostic laboratories tested positive for presence of Tritrichomonas foetus
• The proportion of feline sample submissions testing positive for T.foetus decreased between 2011 and 2018

Bibliographic note

Export Date: 28 February 2019 CODEN: VETRA Correspondence Address: Singleton, D.A.; Institute of Infection and Global HealthUnited States; email: D.A.Singleton@liverpool.ac.uk Funding details: Biotechnology and Biological Sciences Research Council, BBSRC Funding text 1: SAVSNET is based at the University of Liverpool. It is currently funded by the Biotechnology and Biological Sciences Research Council and the British Small Animal Veterinary Association. The SAVSNET team is grateful to the veterinary practices and diagnostic laboratories that provide health data and without whose support these reports would not be possible. It wishes to thank Batt Laboratories, BioBest, CAPL, CTDS, CVS, Idexx, Lab Services, Langford Veterinary Services, NationWide Laboratory Services, PTDS, SRUC, TDDS, Teleos, Test A Pet and Microbiology Diagnostics Laboratory at University of Liverpool, and VetSolutions (the suppliers of RoboVet and PremVet). The team would also like to thank Susan Bolan, SAVSNET project administrator, for her help and support.